Search research articles
Contact Us
Filters
Showing results (11-20 of 88) with videos related to
Page
of 9
Sort By:
Expert Opinion on Drug Discovery
|
June 1, 2012
A drug discovery case history of 'delta-9-tetrahydrocannabinol, cannabidiol'
Radu Tanasescu, David Rog, Cris S Constantinescu
Expert Review of Neurotherapeutics
|
September 30, 2016
The future of multiple sclerosis treatments
Catalina Coclitu, Cris S Constantinescu, Radu Tanasescu
Oncotarget
|
October 14, 2015
TLR2: an innate immune checkpoint in multiple sclerosis
Md Jakir Hossain, Radu Tanasescu, Bruno Gran
Expert Opinion on Biological Therapy
|
April 7, 2018
Recent developments in interferon-based therapies for multiple sclerosis
Laura Dumitrescu, Cris S Constantinescu, Radu Tanasescu
Journal of Neuroimmunology
|
December 24, 2016
Innate immune regulation of autoimmunity in multiple sclerosis: Focus on the role of Toll-like receptor 2
Md Jakir Hossain, Radu Tanasescu, Bruno Gran
Neuropsychiatric Disease and Treatment
|
May 3, 2013
Role of oral teriflunomide in the management of multiple sclerosis
Radu Tanasescu, Nikos Evangelou, Cris S Constantinescu
Expert Opinion on Pharmacotherapy
|
December 6, 2018
Siponimod for the treatment of secondary progressive multiple sclerosis
Laura Dumitrescu, Cris S Constantinescu, Radu Tanasescu
European Journal of Neurology
|
October 11, 2023
The gut-microbiota-brain axis: An introduction to a special issue on its role in neurological disorders
Katrien De Looze, Radu Tanasescu, Kristl Vonck
Expert Review of Neurotherapeutics
|
May 29, 2025
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms
Catalina I Coclitu, Cris S Constantinescu, Radu Tanasescu
Expert Opinion on Biological Therapy
|
June 4, 2015
PEGylated IFNβ-1a in the treatment of multiple sclerosis
Umair Tahir Khan, Radu Tanasescu, Cris S Constantinescu
Page
of 9
Search research articles
Search
Showing results (11-20 of 88) with videos related to
Sort By:
Page
of 9
Expert Opinion on Drug Discovery
|
June 1, 2012
A drug discovery case history of 'delta-9-tetrahydrocannabinol, cannabidiol'
Radu Tanasescu, David Rog, Cris S Constantinescu
Expert Review of Neurotherapeutics
|
September 30, 2016
The future of multiple sclerosis treatments
Catalina Coclitu, Cris S Constantinescu, Radu Tanasescu
Oncotarget
|
October 14, 2015
TLR2: an innate immune checkpoint in multiple sclerosis
Md Jakir Hossain, Radu Tanasescu, Bruno Gran
Expert Opinion on Biological Therapy
|
April 7, 2018
Recent developments in interferon-based therapies for multiple sclerosis
Laura Dumitrescu, Cris S Constantinescu, Radu Tanasescu
Journal of Neuroimmunology
|
December 24, 2016
Innate immune regulation of autoimmunity in multiple sclerosis: Focus on the role of Toll-like receptor 2
Md Jakir Hossain, Radu Tanasescu, Bruno Gran
Neuropsychiatric Disease and Treatment
|
May 3, 2013
Role of oral teriflunomide in the management of multiple sclerosis
Radu Tanasescu, Nikos Evangelou, Cris S Constantinescu
Expert Opinion on Pharmacotherapy
|
December 6, 2018
Siponimod for the treatment of secondary progressive multiple sclerosis
Laura Dumitrescu, Cris S Constantinescu, Radu Tanasescu
European Journal of Neurology
|
October 11, 2023
The gut-microbiota-brain axis: An introduction to a special issue on its role in neurological disorders
Katrien De Looze, Radu Tanasescu, Kristl Vonck
Expert Review of Neurotherapeutics
|
May 29, 2025
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms
Catalina I Coclitu, Cris S Constantinescu, Radu Tanasescu
Expert Opinion on Biological Therapy
|
June 4, 2015
PEGylated IFNβ-1a in the treatment of multiple sclerosis
Umair Tahir Khan, Radu Tanasescu, Cris S Constantinescu
Page
of 9